Clinical Trial: Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia

Study Status: Available
Recruit Status: Available
Study Type: Expanded Access




Official Title: Phase II Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia

Brief Summary: The primary objective of this study is to evaluate the utility of [18F]-DOPA PET to provide improved presurgical planning and distinguish between focal and diffuse forms of HI. The investigators will perform descriptive analysis, relying on visual analysis to diagnose and localize a focal lesion. Our findings will be compared to surgical histopathology to determine sensitivity and specificity or this technique. The investigators will also track patient surgical outcomes, specifically whether the patient is surgically "cured" or still requires medical management to control residual hypoglycemia.